Drug intelligence / Profile preview

conventional arsonoliposomes

Development stage
Preclinical
Lead developer
University of Patras
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Conventional arsonoliposomes are a class of arsenic-containing liposomal nanoparticles composed of arsonolipids, which are synthetic analogs of phospholipids where the phosphorus atom is replaced by arsenic. These "conventional" versions typically utilize ester bonds to link the alkyl chains to the glycerol backbone. They have been extensively studied in preclinical models for their selective anticancer activity, demonstrating the ability to induce apoptosis in various cancer cell lines, including human prostate cancer (PC-3) and Lewis lung carcinoma (LLC), while showing lower toxicity toward normal cells. Their mechanism of action involves the delivery of the arsonolipid monomers to cellular membranes, particularly the mitochondrial membrane, leading to the release of cytochrome c and subsequent cell death.

Other names
arsonoliposomesester-linked arsonoliposomes

Beyond the preview

Go deeper on conventional arsonoliposomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on conventional arsonoliposomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call